Advanced Search

Study Preview



Study Title and Description

Development of hepatocellular carcinoma after interferon therapy in chronic hepatitis C. Is it possible to reduce the incidence by ribanirin and IFN combination therapy?



Key Questions Addressed
9 Key Question 9. What is the association between experiencing SVR following antiviral treatment and reduction in risk of HCV-related adverse health outcomes?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Development of hepatocellular carcinoma after interferon therapy in chronic hepatitis C. Is it possible to reduce the incidence by ribanirin and IFN combination therapy?
Author Izumi N., Yasuhiro A., Kurosaki M., Onuki Y., Nishimura Y., Inoue K., Ueda K., Tsuchiya K., Nakanishi H., Uchihara M., Miyake S.
Country Division of Gastroenterology and Hepatology, Musashino Red-Cross Hospital, Tokyo, Japan. nizumi@musashino.jrc.or.jp
Year 2005
Numbers Pubmed ID: 15785091

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-9


Results & Comparisons

No Results found.